adecatumumab MT#

Related by string. * Adecatumumab : evaluating adecatumumab . adecatumumab . developing adecatumumab / MT# [002] . MT# [003] . MT# [001] : Mosler MT# . MediaTek MT# . Microtune MT# . candidate blinatumomab MT# . MT# 1ST DOWN . BiTE antibody MT# . MT# tuner . MicroTuner MT# . MicroTuner TM MT# . PM MT# . MT# MEDI . AM MT# . antibody MT# . MT# COV . stage antibody MT# . Rolls Royce MT# . Motorola MT# * *

Related by context. Frequent words. (Click for all words.) 73 Initiate Phase 71 elotuzumab 70 refractory chronic lymphocytic 70 Phase Ib II 69 PEG SN# 69 R sorafenib tablets 68 Initiates Phase 68 GVAX R 68 phase Ib 68 liposomal formulation 68 humanized anti 67 forodesine 67 proteasome inhibitor 67 IMC #B 67 phase IIb clinical 67 targeting CD# 66 Presents Positive 66 Panzem R 66 Daclizumab 66 Inc. Nasdaq IMGN 66 drug conjugate 66 Phase Ib clinical 66 SAR# [004] 66 Amrubicin 66 Pivotal Phase 66 MEK inhibitor 66 HGS ETR1 65 Pivotal Phase III 65 polymerase inhibitor 65 Nexavar ® 65 Phase 1b trial 65 adecatumumab 65 metastatic castration resistant 65 subcutaneous formulation 65 axitinib 65 PXD# 65 enzastaurin 65 multicenter Phase 65 ganetespib 64 JAK1 64 Factor VIIa 64 Epratuzumab 64 sunitinib malate 64 phase IIa clinical 64 PEG Interferon lambda 64 atacicept 64 orally bioavailable 64 PSN# [002] 64 TOCOSOL Paclitaxel 63 romidepsin 63 Sym# 63 eniluracil 63 Bicifadine 63 TLR9 agonist 63 talactoferrin 63 Recombinant Human 63 Ixempra 63 metastatic castrate resistant 63 multi kinase inhibitor 63 Phenoptin 63 phase IIa 63 Nasdaq ENZN 63 BiTE antibody 63 HCV protease inhibitor 63 INCB# [001] 63 non nucleoside polymerase 63 dacetuzumab 63 Nasdaq VRTX 63 registrational 63 placebo controlled Phase 63 MORAb 63 ocrelizumab 63 epothilone 63 Thiarabine 63 deforolimus 63 Aurora kinase 63 anti CD# monoclonal 63 ASONEP 63 Rebif ® 63 MOZOBIL 63 CR# vcMMAE 63 Tesetaxel 62 CYC# 62 phase IIb 62 Phase 2b clinical trials 62 hypoxia inducible factor 62 docetaxel chemotherapy 62 OXi# 62 MAXY G# 62 bendamustine 62 multiple myeloma MM 62 metastatic hormone refractory 62 ALN TTR# 62 amrubicin 62 See BioWorld Today 62 ridaforolimus 62 ixabepilone 62 vascular disrupting agent 62 ATL# [001] 62 selectively inhibits 62 refractory multiple myeloma

Back to home page